BPA Call 36C25018A0002-36C25018N1393
Award Date
2/6/18
Potential Completion Date
7/31/18
Potential Value
$119K
Federal Agency
Veterans Integrated Service Network 10
Awardee
Baxalta US Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Riverwoods, IL 60015, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Baxalta US Inc., a foreign-owned, for-profit pharmaceutical company, by the U.S. Department of Veterans Affairs (VA). The contract is a Blanket Purchase Agreement (BPA) call order under Baxalta's existing GSA Schedule 61-IB contract for Pharmaceuticals and Drugs. The awarded contract has a firm-fixed price of $105,560.00 and is for the delivery of the specialty pharmaceutical drug GLASSIA (alpha 1-proteinase inhibitor). The contract has an ultimate...
This is a firm fixed-price delivery order against the Pharmaceuticals and Drugs (FSS-61-IB) schedule contract, awarded by the Department of Veterans Affairs (VA) to Baxalta US Inc., a foreign-owned, for-profit pharmaceutical company. The award, valued at $217,000.00, is for the supply of 1,200 vials of the drug GLASSIA (alpha 1-proteinase inhibitor human, 1 gram/50 milliliters) for the VA's fiscal year 2016 requirements. The contract has a period of performance ending on September 30, 2016 and...
This is a $75,310.20 firm fixed-price delivery order contract awarded by the U.S. Department of Veterans Affairs (VA) to Baxalta US Inc., a foreign-owned for-profit pharmaceutical company, for the supply of blood products. The contract is issued against Baxalta's General Services Administration (GSA) Federal Supply Schedule 61-IB for Pharmaceuticals and Drugs. No set-aside designation was used for this award. Baxalta has previously received other prime contract awards from the VA, Department...
This is a firm fixed-price delivery order contract awarded by the Department of Veterans Affairs (VA) to Baxalta US Inc., a foreign-owned, for-profit pharmaceutical company, under the GSA Pharmaceuticals and Drugs schedule contract. The contract is for the provision of BLOOD PRODUCT with a ceiling value of $113,835.30 and a period of performance ending on December 15, 2016. The contract was awarded on December 15, 2016 and was not set aside for any specific business type. Baxalta US Inc....
This is a delivery order contract awarded by the Veterans Integrated Service Network 10 (VISN 10) of the U.S. Department of Veterans Affairs to Baxalta US Inc., a foreign-owned, for-profit pharmaceutical company. The contract is for the delivery of blood products, valued at $228,097.10, and is based on Baxalta's existing General Services Administration (GSA) Pharmaceuticals and Drugs schedule contract. The contract has a completion date of May 12, 2017 and is a firm fixed-price delivery order....
This is a federal contract award to Baxalta US Inc., a foreign-owned, for-profit pharmaceutical company, by the U.S. Department of Veterans Affairs' Veterans Integrated Service Network 21. The contract is for the delivery of Globulin, Immune (IV) 30GM/Vial, a specialty pharmaceutical product, under the General Services Administration (GSA) Pharmaceuticals and Drugs schedule contract. The contract has a ceiling value of $79,748.10 and an ultimate completion date of September 30, 2019. No...
This is a delivery order issued by the Veterans Integrated Service Network 7 (VISN 7) of the U.S. Department of Veterans Affairs to the prime contractor Baxalta US Inc. The order is for FEIDA DRUG, which is likely a pharmaceutical product. The contract is awarded under Baxalta's General Services Administration (GSA) Pharmaceuticals and Drugs schedule contract and has a firm fixed price of $187,137.60. The contract has an ultimate completion date of November 7, 2016. Baxalta US Inc. is a...
This is a federal contract award to Baxalta US Inc., a foreign-owned, for-profit pharmaceutical company, by the Veterans Integrated Service Network 7 of the Department of Veterans Affairs. The contract award, with a ceiling value of $110,361.60, is for the delivery of FEIBA, a pharmaceutical product, under the GSA Pharmaceuticals and Drugs schedule contract. The contract is a firm fixed-price delivery order with an ultimate completion date of October 26, 2016. No set-aside designation was used...
This is a delivery order contract awarded by the Department of Veterans Affairs (VA) to Baxalta US Inc., a foreign-owned for-profit pharmaceutical company. The $137,952.00 firm fixed-price contract is for the delivery of FEIBA, a specialty drug used to treat bleeding disorders. The contract was awarded under Baxalta's existing Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB). No set-aside designation was used for this award. Through its FSS contract, Baxalta has...
This is a delivery order contract awarded by the Veterans Integrated Service Network 22 (VISN 22) of the U.S. Department of Veterans Affairs (VA) to Baxalta US Inc., a foreign-owned for-profit pharmaceutical company. The contract is for the provision of FEIBA, a pharmaceutical product, to the VA system. The contract has a ceiling value of $89,821.60 and was awarded on October 5, 2018, with a period of performance ending on September 30, 2019. The contract was placed against Baxalta's existing...